<p>Aemetis（纳斯达克代码：AMTX - 获取免费报告）于周四公布了其财报。该特种化学公司报告本季度每股收益为（$0.37），低于市场共识预期的（$0.25），差距为（$0.12），据 Zacks 报道。该公司本季度的收入为 5919 万美元，而分析师预期为 8779 万美元。</p>
<h2>Aemetis 股价上涨 19.3%</h2>
<p>周五午盘交易中，AMTX 股票上涨 0.34 美元，达到 2.10 美元。该股票的交易量为 1,324,071 股，而其平均交易量为 999,169 股。Aemetis 的 52 周低点为 1.22 美元，52 周高点为 4.73 美元。该公司的 50 日简单移动平均线为 2.46 美元，200 日简单移动平均线为 2.31 美元。公司的市值为 1.3281 亿美元，市盈率为-1.30，贝塔值为 1.73。</p>
<h2>华尔街分析师预测增长</h2>
<p>几位股票研究分析师最近对 AMTX 股票发表了评论。Ascendiant Capital Markets 将 Aemetis 的目标股价从 20.00 美元上调至 21.00 美元，并在 10 月 6 日的报告中给予该股票 “买入” 评级。Weiss Ratings 在 10 月 8 日的研究报告中重新发布了对 Aemetis 的 “卖出（e+）” 评级。三位分析师给予该股票 “买入” 评级，一位分析师给予该股票 “卖出” 评级。根据 MarketBeat 的数据，Aemetis 目前的共识评级为 “适度买入”，共识目标价为 17.33 美元。</p>
<p><strong>获取我们对 Aemetis 的最新股票分析</strong></p>
<h2>Aemetis 内部活动</h2>
<p>在其他消息中，董事 Francis P. Barton 于 8 月 14 日星期四出售了 26,452 股公司的股票。该股票以平均价格 2.53 美元出售，总价值为 66,923.56 美元。交易后，该董事直接持有 208,518 股公司的股票，估值约为 527,550.54 美元。此交易代表其持股比例减少了 11.26%。该交易已在 SEC 的备案中披露，具体信息可在此链接查看。14.70% 的股票由公司内部人士持有。</p>
<h2>机构资金流入和流出</h2>
<p>一些机构投资者最近买入和卖出了该公司的股票。Vanguard Group Inc.在第三季度将其在 Aemetis 的持股增加了 15.3%。Vanguard Group Inc.目前持有 2,479,163 股特种化学公司的股票，价值为 5,578,000 美元，此前在上个季度增持了 329,760 股。Jane Street Group LLC 在第二季度收购了 Aemetis 的新股份，价值约为 634,000 美元。Qube Research &amp; Technologies Ltd 在第二季度购买了 Aemetis 的新股份，价值约为 246,000 美元。Jump Financial LLC 在第二季度购买了 Aemetis 的新股份，价值约为 64,000 美元。最后，Russell Investments Group Ltd.在第二季度将其在 Aemetis 的持股增加了 412.9%。Russell Investments Group Ltd.目前持有 80,754 股特种化学公司的股票，价值为 200,000 美元，此前增持了 65,010 股。27.02% 的股票由对冲基金和其他机构投资者持有。</p>
<h2>关于 Aemetis</h2>
<p>（获取免费报告）</p>
<p>Aemetis, Inc 是一家可再生天然气和可再生燃料公司。它通过三个部门运营：加州乙醇、加州乳制品可再生天然气和印度生物柴油。该公司专注于运营、收购、开发和商业化技术，以生产低碳和负碳强度的可再生燃料，以替代基于化石的产品。</p>
<h2>另见</h2>
<ul>
<li>五只我们更看好的股票比 Aemetis 更好</li>
<li>什么是 MarketRank™？如何使用它</li>
<li>OpenAI 的重组可能会成为有史以来最大的 IPO</li>
<li>股票中的缺口上涨意味着什么？如何利用缺口</li>
<li>美国政府不希望失败的两只稀土股票</li>
<li>使用 MarketBeat 股息收益计算器</li>
<li>CrowdStrike 与 CoreWeave 合作，但投资者抛售消息</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QU1UWA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QU1UWA"/></p>
<p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或评论发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 Aemetis 1,000 美元吗？</h2>
<p>在考虑 Aemetis 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐的股票。MarketBeat 已识别出五只顶级分析师正在悄悄向客户推荐的股票，以便在更广泛的市场注意到之前购买……而 Aemetis 并不在名单上。</p>
<p>虽然 Aemetis 目前在分析师中获得了适度买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

AMTX

<p>Aemetis（纳斯达克代码：AMTX）报告的季度每股收益为（$0.37），低于预期的（$0.25），差距为$0.12。收入为 5919 万美元，低于预期的 8779 万美元。公告后，股价上涨 19.3%，至$2.10。分析师对该公司的共识评级为 “适度买入”，目标价为$17.33。最近的内部交易显示，董事 Francis P. Barton 出售了 26,452 股。机构投资者增加了持股，先锋集团（Vanguard Group）将其持仓提高了 15.3%。Aemetis 专注于可再生燃料，并在加利福尼亚州和印度运营</p>

<p>Aemetis (NASDAQ:AMTX - Get Free Report) announced its earnings results on Thursday. The specialty chemicals company reported ($0.37) earnings per share for the quarter, missing the consensus estimate of ($0.25) by ($0.12), Zacks reports. The firm had revenue of $59.19 million during the quarter, compared to analyst estimates of $87.79 million.</p>
<div class="lb-trans"><p>Aemetis（纳斯达克代码：AMTX - 获取免费报告）于周四公布了其财报。该特种化学公司报告本季度每股收益为（$0.37），低于市场共识预期的（$0.25），差距为（$0.12），据 Zacks 报道。该公司本季度的收入为 5919 万美元，而分析师预期为 8779 万美元。</p>
</div><h2>Aemetis Trading Up 19.3%</h2>
<div class="lb-trans"><h2>Aemetis 股价上涨 19.3%</h2>
</div><p>AMTX stock traded up $0.34 during midday trading on Friday, reaching $2.10. The stock had a trading volume of 1,324,071 shares, compared to its average volume of 999,169. Aemetis has a 52-week low of $1.22 and a 52-week high of $4.73. The company's fifty day simple moving average is $2.46 and its 200 day simple moving average is $2.31. The company has a market cap of $132.81 million, a price-to-earnings ratio of -1.30 and a beta of 1.73.</p>
<div class="lb-trans"><p>周五午盘交易中，AMTX 股票上涨 0.34 美元，达到 2.10 美元。该股票的交易量为 1,324,071 股，而其平均交易量为 999,169 股。Aemetis 的 52 周低点为 1.22 美元，52 周高点为 4.73 美元。该公司的 50 日简单移动平均线为 2.46 美元，200 日简单移动平均线为 2.31 美元。公司的市值为 1.3281 亿美元，市盈率为-1.30，贝塔值为 1.73。</p>
</div><h2>Wall Street Analysts Forecast Growth</h2>
<div class="lb-trans"><h2>华尔街分析师预测增长</h2>
</div><p>Several equities research analysts recently commented on AMTX shares. Ascendiant Capital Markets boosted their price target on shares of Aemetis from $20.00 to $21.00 and gave the stock a &#34;buy&#34; rating in a report on Monday, October 6th. Weiss Ratings reissued a &#34;sell (e+)&#34; rating on shares of Aemetis in a research note on Wednesday, October 8th. Three analysts have rated the stock with a Buy rating and one has given a Sell rating to the stock. According to data from MarketBeat, Aemetis presently has a consensus rating of &#34;Moderate Buy&#34; and a consensus price target of $17.33.</p>
<div class="lb-trans"><p>几位股票研究分析师最近对 AMTX 股票发表了评论。Ascendiant Capital Markets 将 Aemetis 的目标股价从 20.00 美元上调至 21.00 美元，并在 10 月 6 日的报告中给予该股票 “买入” 评级。Weiss Ratings 在 10 月 8 日的研究报告中重新发布了对 Aemetis 的 “卖出（e+）” 评级。三位分析师给予该股票 “买入” 评级，一位分析师给予该股票 “卖出” 评级。根据 MarketBeat 的数据，Aemetis 目前的共识评级为 “适度买入”，共识目标价为 17.33 美元。</p>
</div><p><strong>Get Our Latest Stock Analysis on Aemetis</strong></p>
<div class="lb-trans"><p><strong>获取我们对 Aemetis 的最新股票分析</strong></p>
</div><h2>Insider Activity at Aemetis</h2>
<div class="lb-trans"><h2>Aemetis 内部活动</h2>
</div><p>In other news, Director Francis P. Barton sold 26,452 shares of the firm's stock in a transaction dated Thursday, August 14th. The shares were sold at an average price of $2.53, for a total value of $66,923.56. Following the transaction, the director directly owned 208,518 shares of the company's stock, valued at approximately $527,550.54. This trade represents a 11.26% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. 14.70% of the stock is owned by company insiders.</p>
<div class="lb-trans"><p>在其他消息中，董事 Francis P. Barton 于 8 月 14 日星期四出售了 26,452 股公司的股票。该股票以平均价格 2.53 美元出售，总价值为 66,923.56 美元。交易后，该董事直接持有 208,518 股公司的股票，估值约为 527,550.54 美元。此交易代表其持股比例减少了 11.26%。该交易已在 SEC 的备案中披露，具体信息可在此链接查看。14.70% 的股票由公司内部人士持有。</p>
</div><h2>Institutional Inflows and Outflows</h2>
<div class="lb-trans"><h2>机构资金流入和流出</h2>
</div><p>A number of institutional investors have recently bought and sold shares of the business. Vanguard Group Inc. boosted its position in shares of Aemetis by 15.3% during the 3rd quarter. Vanguard Group Inc. now owns 2,479,163 shares of the specialty chemicals company's stock valued at $5,578,000 after acquiring an additional 329,760 shares during the last quarter. Jane Street Group LLC acquired a new stake in Aemetis during the second quarter worth about $634,000. Qube Research &amp; Technologies Ltd purchased a new position in Aemetis during the second quarter worth about $246,000. Jump Financial LLC purchased a new position in Aemetis during the second quarter worth about $64,000. Finally, Russell Investments Group Ltd. boosted its holdings in Aemetis by 412.9% in the 2nd quarter. Russell Investments Group Ltd. now owns 80,754 shares of the specialty chemicals company's stock valued at $200,000 after purchasing an additional 65,010 shares during the last quarter. 27.02% of the stock is owned by hedge funds and other institutional investors.</p>
<div class="lb-trans"><p>一些机构投资者最近买入和卖出了该公司的股票。Vanguard Group Inc.在第三季度将其在 Aemetis 的持股增加了 15.3%。Vanguard Group Inc.目前持有 2,479,163 股特种化学公司的股票，价值为 5,578,000 美元，此前在上个季度增持了 329,760 股。Jane Street Group LLC 在第二季度收购了 Aemetis 的新股份，价值约为 634,000 美元。Qube Research &amp; Technologies Ltd 在第二季度购买了 Aemetis 的新股份，价值约为 246,000 美元。Jump Financial LLC 在第二季度购买了 Aemetis 的新股份，价值约为 64,000 美元。最后，Russell Investments Group Ltd.在第二季度将其在 Aemetis 的持股增加了 412.9%。Russell Investments Group Ltd.目前持有 80,754 股特种化学公司的股票，价值为 200,000 美元，此前增持了 65,010 股。27.02% 的股票由对冲基金和其他机构投资者持有。</p>
</div><h2>About Aemetis</h2>
<div class="lb-trans"><h2>关于 Aemetis</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>Aemetis, Inc operates as a renewable natural gas and renewable fuels company. It operates through three segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the operation, acquisition, development, and commercialization of technologies to produce low and negative carbon intensity renewable fuels that replace fossil-based products.</p>
<div class="lb-trans"><p>Aemetis, Inc 是一家可再生天然气和可再生燃料公司。它通过三个部门运营：加州乙醇、加州乳制品可再生天然气和印度生物柴油。该公司专注于运营、收购、开发和商业化技术，以生产低碳和负碳强度的可再生燃料，以替代基于化石的产品。</p>
</div><h2>See Also</h2>
<div class="lb-trans"><h2>另见</h2>
</div><ul>
<li>Five stocks we like better than Aemetis</li>
<li>What is MarketRank™? How to Use it</li>
<li>OpenAI's Restructuring Sets up What Could Be the Biggest IPO Ever</li>
<li>What Does a Gap Up Mean in Stocks? How to Play the Gap</li>
<li>2 Rare Earth Stocks the U.S. Government Doesn’t Want to Fail</li>
<li>Using the MarketBeat Dividend Yield Calculator</li>
<li>CrowdStrike Partners With CoreWeave But Investors Sell the News</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们更看好的股票比 Aemetis 更好</li>
<li>什么是 MarketRank™？如何使用它</li>
<li>OpenAI 的重组可能会成为有史以来最大的 IPO</li>
<li>股票中的缺口上涨意味着什么？如何利用缺口</li>
<li>美国政府不希望失败的两只稀土股票</li>
<li>使用 MarketBeat 股息收益计算器</li>
<li>CrowdStrike 与 CoreWeave 合作，但投资者抛售消息</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QU1UWA" alt="" original-src="https://www.marketbeat.com/scripts/EarningsChart.ashx?Prefix=NASDAQ&amp;Symbol=AMTX"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或评论发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Aemetis Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 Aemetis 1,000 美元吗？</h2>
</div><p>Before you consider Aemetis, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 Aemetis 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aemetis wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐的股票。MarketBeat 已识别出五只顶级分析师正在悄悄向客户推荐的股票，以便在更广泛的市场注意到之前购买……而 Aemetis 并不在名单上。</p>
</div><p>While Aemetis currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Aemetis 目前在分析师中获得了适度买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Aemetis（NASDAQ:AMTX）公布了财报，每股收益比预期低 0.12 美元